EQT CORP./ US26884L1098 /
2024-05-17 10:58:10 PM | Chg. +0.580 | Volume | Bid10:58:10 PM | Ask10:58:10 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
37.410EUR | +1.57% | - Turnover: - |
37.410Bid Size: - | 38.330Ask Size: - | 16.73 bill.EUR | - | - |
GlobeNewswire
05-13
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reneo Pharm...
GlobeNewswire
05-06
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ALLETE, Inc...
GlobeNewswire
05-06
Is Perficient's $76 Per Share Sale Price Fair? Johnson Fistel, LLP Investigates Deal Terms
GlobeNewswire
05-06
PRFT Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Perficient to EQT A...
GlobeNewswire
04-18
GA Drilling Announces First Close of $15M to Accelerate the Delivery of Deep Geothermal Energy
GlobeNewswire
03-21
Angelini Ventures invests into extended €75.8 million ($82 million) Series C financing round for Nou...
GlobeNewswire
03-21
ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookb...
GlobeNewswire
03-20
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Publi...
GlobeNewswire
03-20
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Publi...
GlobeNewswire
03-20
FundaMental Pharma Appoints Industry Veteran Dr. Lorenz Mayr as Non-Executive Director
GlobeNewswire
03-15
STOCKHOLDER ALERT: The M&A Class Action Launches Investigation of the Merger – EVRI, ANSS, ETRN, VIV...